Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat in Non-Dialysis Chronic Kidney Disease Patients With Anemia
NCT01244763Phase 2Completed
- Sponsor
- FibroGen
- Start
- Oct 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of roxadustat in anemia of chronic kidney disease (CKD-A) (6 cohorts), sponsored by FibroGen. Primary endpoint: Number (%) of Participants With an Hb Response by Week 17. Started Oct 2010; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01244763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244763.